Eton Pharmaceuticals (ETON) Assets (2017 - 2025)

Eton Pharmaceuticals (ETON) has 9 years of Assets data on file, last reported at $92.1 million in Q4 2025.

• For the quarter ending Q4 2025, Assets rose 21.01% year-over-year to $92.1 million; the trailing twelve-month figure through Dec 2025 stood at $92.1 million (up 21.01% YoY), and the FY2025 full-year result was $92.1 million, up 21.01% from the prior year.
• Assets retreated to $92.1 million in Q4 2025, from $104.5 million in the prior quarter.
• In the past five years, Assets ranged from a high of $104.5 million in Q3 2025 to a low of $21.5 million in Q3 2022.
• A 5-year average of $44.1 million and a median of $31.1 million in 2021 frame the typical range for Assets.
• Across the five-year window, Assets fell 25.62% in 2022 and jumped 219.5% in 2025, its largest moves.
• Tracing ETON's Assets over 5 years: stood at $27.5 million in 2021, then slipped by 8.87% to $25.0 million in 2022, then grew by 26.81% to $31.7 million in 2023, then jumped by 139.83% to $76.1 million in 2024, then grew by 21.01% to $92.1 million in 2025.
• Business Quant data shows ETON's Assets at $92.1 million in Q4 2025, $104.5 million in Q3 2025, and $101.7 million in Q2 2025.